VERTEX PHARMACEUTICALS INC / MA
VRTXSEC CIK 875320Price charts ↗
Writing the earnings story…
Financials
Revenue+7.8% YoY
$2.99B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+59.6% YoY
$1.03B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+61.4% YoY
$4.02
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
—
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Mar 2026 | $2.99B | $1.03B | $4.02 |
| Sep 2025 | $3.08B | $1.08B | $4.2 |
| Jun 2025 | $2.96B | $1.03B | $3.99 |
| Mar 2025 | $2.77B | $646.3M | $2.49 |
| Sep 2024 | $2.77B | $1.05B | $4.01 |
| Jun 2024 | $2.65B | -$3.59B | -$13.92 |
| Mar 2024 | $2.69B | $1.10B | $4.21 |
| Sep 2023 | $2.48B | $1.04B | $3.97 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-05-05 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-13 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-11-04 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-08-05 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-05-06 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-13 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-11-05 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-08-02 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.